Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity

Our data demonstrated that EGCG improved IR, possibly through ameliorating glucose (25 mM) and PA (0.25 mM)-induced inflammation, oxidative stress, and FFAs via the GLUT2/PGC-1β/SREBP-1c/FAS pathway in HepG2 cells.